Ogen: Medgend

Search instead for gene

Ogen FDA Approved Drugs

ALA-CORT [Hydrocortisone^{C₂₁H₃₀O₅}]

1% (topical cream)

2.5% (topical cream)

Crown Labs^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ALA-SCALP [Hydrocortisone^{C₂₁H₃₀O₅}]

2% (topical lotion)

Crown Labs^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ALTABAX [Retapamulin^{C₃₀H₄₇NO₄S}]

1% (topical ointment)

Aqua Pharms Llc^{Apr 12, 2007}

Treatment of impetigo due to staphylococcus aureus or streptococcus pyogenes.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ANDROGEL [Testosterone^{C₁₉H₂₈O₂}]

1.62% (20.25mg/1.25gm actuation) (transdermal gel, metered)

1.62% (20.25mg/1.25gm packet) (transdermal gel)

1.62% (40.5mg/2.5gm packet) (transdermal gel)

12.5mg/1.25gm actuation (transdermal gel, metered)

25mg/2.5gm packet (transdermal gel)

50mg/5gm packet (transdermal gel)

Abbvie^{Apr 29, 2011}

Testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ANUSOL HC [Hydrocortisone^{C₂₁H₃₀O₅}]

2.5% (topical cream)

Salix Pharms^{Jun 6, 1984}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

AUGMENTIN XR [Amoxicillin^{C₁₆H₁₉N₃O₅S3H₂O} : Clavulanate Potassium^{C₈H₈NO₅K}]

1gm : eq 62.5mg base (oral tablet, extended release)

Dr Reddys Labs Inc^{Sep 25, 2002}

Mgt specific bacterial infections. treatment pts w/ community acquired pneumonia or bacterial sinusitis due to confirmed, or suspected b-lactamase producing pathogens & s. pneumoniae with reduced susceptibility to penicillin (mic=2mc/ml).

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

AVEED [Testosterone Undecanoate^{C₃₀H₄₈O₃}]

750mg/3ml (250mg/ml) (intramuscular injectable)

Endo Pharms Inc^{Mar 5, 2014}

Testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; primary hypogonadism (congenital or acquired); hypogonadotropic hypogonadism (congenital or acquired)..

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

AXIRON [Testosterone^{C₁₉H₂₈O₂}]

30mg/1.5ml actuation (transdermal solution, metered)

Eli Lilly And Co^{Nov 23, 2010}

A method of increasing the testosterone blood level of a person in need thereof.
A method of increasing the testosterone blood level of an adult male subject in need thereof.
A method of transdermal administration of a physiologically active agent to a subject..
A method of transdermally delivering testosterone.
Testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

BEKYREE [Desogestrel^{C₂₂H₃₀O} : Ethinyl Estradiol^{C₂₀H₂₄O₂}]

0.15mg,n/a : 0.02mg,0.01mg (oral-28 tablet)

Lupin Ltd^{Aug 12, 2015}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

BENZTROPINE MESYLATE [Benztropine Mesylate^{C₂₁H₂₅NOCH₄O₃S}]

0.5mg (oral tablet)

1mg (oral tablet)

1mg/ml (injection injectable)

2mg (oral tablet)

Aspen Global Inc^{Apr 14, 2015}
Epic Pharma Llc^{Feb 27, 1989}
Invagen Pharms^{Mar 29, 2010}
Leading Pharma Llc^{Nov 28, 2012}
Oxford Pharms^{Feb 14, 2008}
Pliva^{Aug 10, 1988}
Usl Pharma^{Dec 12, 1996}
Vintage^{Aug 27, 2007}
Fresenius Kabi Usa^{Jul 28, 2009}
Hikma Farmaceutica^{Aug 31, 2009}
Luitpold^{Mar 29, 2010}
Navinta Llc^{Feb 5, 2013}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

BOSULIF [Bosutinib Monohydrate^{C₂₆H₂₉Cl₂N₅O₃H₂O}]

eq 100mg base (oral tablet)

eq 500mg base (oral tablet)

Pf Prism Cv^{Sep 4, 2012}

A method of treating a neoplasm.
A method of treating chronic myelogenous leukemia.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CARDIOGEN-82 [Rubidium Chloride Rb-82^ClRb]

n/a (injection injectable)

Bracco^{Dec 29, 1989}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

COGENTIN [Benztropine Mesylate^{C₂₁H₂₅NOCH₄O₃S}]

1mg/ml (injection injectable)

Oak Pharms Akorn^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

COLOCORT [Hydrocortisone^{C₂₁H₃₀O₅}]

100mg/60ml (rectal enema)

Paddock Llc^{Dec 3, 1999}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CORTEF [Hydrocortisone^{C₂₁H₃₀O₅}]

10mg (oral tablet)

20mg (oral tablet)

5mg (oral tablet)

Pharmacia And Upjohn^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CORTENEMA [Hydrocortisone^{C₂₁H₃₀O₅}]

100mg/60ml (rectal enema)

Ani Pharms^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CYCLESSA [Desogestrel^{C₂₂H₃₀O} : Ethinyl Estradiol^{C₂₀H₂₄O₂}]

0.1mg,0.125mg,0.15mg : 0.025mg,0.025mg,0.025mg (oral-28 tablet)

Aspen Global Inc^{Dec 20, 2000}

efficacy
0.0 (0)

side effects
0.0 (0)

DACOGEN [Decitabine^{C₈H₁₂N₄O₄}]

50mg/vial (intravenous injectable)

Otsuka Pharm Co Ltd^{May 2, 2006}

DECITABINE [Decitabine^{C₈H₁₂N₄O₄}]

50mg/vial (intravenous injectable)

Accord Hlthcare^{Feb 27, 2017}
Dr Reddys Labs Ltd^{Jul 11, 2013}
Pharmascience Inc^{May 31, 2017}
Sandoz Inc^{Aug 28, 2014}
Sun Pharma Global^{Jan 28, 2014}

DELESTROGEN [Estradiol Valerate^{C₂₃H₃₂O₃}]

10mg/ml (injection injectable)

20mg/ml (injection injectable)

40mg/ml (injection injectable)

Par Sterile Products^{Approved Prior To Jan 1, 1982}

DESOGEN [Desogestrel^{C₂₂H₃₀O} : Ethinyl Estradiol^{C₂₀H₂₄O₂}]

0.15mg : 0.03mg (oral-28 tablet)

Organon Usa Inc^{Dec 10, 1992}

DESOGESTREL AND ETHINYL ESTRADIOL [Desogestrel^{C₂₂H₃₀O} : Ethinyl Estradiol^{C₂₀H₂₄O₂}]

0.15mg,n/a : 0.02mg,0.01mg (oral-28 tablet)

0.15mg : 0.03mg (oral-28 tablet)

0.1mg,0.125mg,0.15mg : 0.025mg,0.025mg,0.025mg (oral-28 tablet)

Accord Hlthcare^{Jun 5, 2017}
Aurobindo Pharma Ltd^{Mar 22, 2017}
Mayne Pharma^{Dec 29, 2008}
Mylan Labs Ltd^{Aug 30, 2013}
Duramed Pharms Barr^{Aug 12, 1999}
Novast Labs Ltd^{Jul 12, 2013}
Watson Labs^{Jul 29, 2005}

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE [Atropine Sulfate^{2C₁₇H₂₃NO₃H₂OH₂O₄S} : Diphenoxylate Hydrochloride^{C₃₀H₃₂N₂O₂ClH}]

0.025mg/5ml : 2.5mg/5ml (oral solution)

0.025mg : 2.5mg (oral tablet)

West-ward Pharms Int^{May 3, 1982}
Ani Pharms Inc^{Approved Prior To Jan 1, 1982}
Lannett^{Approved Prior To Jan 1, 1982}
Mylan^{Approved Prior To Jan 1, 1982}
Par Pharm^{May 2, 2000}

DUAVEE [Bazedoxifene Acetate^{C₃₀H₃₄N₂O₃C₂H₄O₂} : Estrogens, Conjugated]

eq 20mg base : 0.45mg (oral tablet)

Wyeth Pharms Pfizer^{Oct 3, 2013}

Prevention of postmenopausal osteoporosis.
Treatment of moderate to severe vasomotor symptoms associated with menopause.

EMOQUETTE [Desogestrel^{C₂₂H₃₀O} : Ethinyl Estradiol^{C₂₀H₂₄O₂}]

0.15mg : 0.03mg (oral-28 tablet)

Vintage Pharms Llc^{Feb 25, 2011}

ENJUVIA [Estrogens, Conjugated Synthetic B]

0.3mg (oral tablet)

0.45mg (oral tablet)

0.9mg (oral tablet)

Teva Branded Pharm^{Dec 20, 2004}

Treatment of moderate to severe vaginal dryness and pain with intercourse, symptoms of vulvar and vaginal atrophy, associated with menopause.
Treatment of moderate to severe vasomotor symptoms associated with menopause.

ENSKYCE [Desogestrel^{C₂₂H₃₀O} : Ethinyl Estradiol^{C₂₀H₂₄O₂}]

0.15mg : 0.03mg (oral-28 tablet)

Lupin Ltd^{Mar 7, 2013}

ERGOLOID MESYLATES [Ergoloid Mesylates]

1mg (oral tablet)

Sun Pharm Inds^{Oct 31, 1991}

ESTRADIOL VALERATE [Estradiol Valerate^{C₂₃H₃₂O₃}]

20mg/ml (injection injectable)

40mg/ml (injection injectable)

Luitpold^{Jan 19, 2010}

ESTROPIPATE [Estropipate^{C₁₈H₂₂O₅SC₄H₁₀N₂}]

0.75mg (oral tablet)

1.5mg (oral tablet)

3mg (oral tablet)

Mylan^{Aug 26, 1999}
Watson Labs^{Sep 23, 1993}
Watson Labs Teva^{Sep 23, 1993}

FACTIVE [Gemifloxacin Mesylate^{C₁₈H₂₀FN₅O₄CH₄O₃S}]

eq 320mg base (oral tablet)

Lg Chem Ltd^{Apr 4, 2003}

Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria.
Use of quinolone compounds against anaerobic pathogenic bacteria.
Use of quinolone compounds against atypical upper respiratory pathogenic bacteria.
Use of quinolone compounds against pneumococcal pathogenic bacteria.
Use of quinolone compounds against quinolone-resistant pneumococcal pathogenic bacteria.

FASLODEX [Fulvestrant^{C₃₂H₄₇F₅O₃S}]

50mg/ml (intramuscular injectable)

Astrazeneca^{Apr 25, 2002}

Treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
Treatment of hr-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in combination with palbococlib in women with disease progression after endocrine therapy.

FORTESTA [Testosterone^{C₁₉H₂₈O₂}]

10mg/0.5gm actuation (transdermal gel, metered)

Endo Pharms^{Dec 29, 2010}

Testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.

GENOPTIC [Gentamicin Sulfate]

eq 0.3% base (ophthalmic solution/drops)

Allergan^{Oct 10, 1984}

GENTAK [Gentamicin Sulfate]

eq 0.3% base (ophthalmic solution/drops)

Akorn^{Oct 12, 2001}

GENTAMICIN SULFATE [Gentamicin Sulfate]

eq 0.1% base (topical ointment)

eq 0.3% base (ophthalmic ointment)

eq 10mg base/ml (injection injectable)

eq 40mg base/ml (injection injectable)

Fougera Pharms Inc^{Oct 5, 1984}
G And W Labs Inc^{Apr 29, 1994}
Perrigo New York^{Approved Prior To Jan 1, 1982}
Taro^{Dec 23, 1983}
Akorn^{Aug 31, 1995}
Bausch And Lomb^{May 11, 1994}
Perrigo Co Tennessee^{Jan 30, 2004}
Sandoz Inc^{Approved Prior To Jan 1, 1982}
Fresenius Kabi Usa^{Feb 6, 1986}
Hospira^{Aug 15, 1983}

GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER [Gentamicin Sulfate]

eq 1.2mg base/ml (injection injectable)

eq 1.6mg base/ml (injection injectable)

eq 100mg base/100ml (injection injectable)

eq 120mg base/100ml (injection injectable)

eq 2mg base/ml (injection injectable)

eq 80mg base/100ml (injection injectable)

Baxter Hlthcare^{Sep 7, 1982}
Hospira^{Aug 15, 1983}

HYDROCORTISONE [Hydrocortisone^{C₂₁H₃₀O₅}]

1% (topical cream)

100mg/60ml (rectal enema)

10mg (oral tablet)

2.5% (topical cream)

20mg (oral tablet)

5mg (oral tablet)

Actavis Mid Atlantic^{May 3, 1983}
Fougera Pharms^{Approved Prior To Jan 1, 1982}
Fougera Pharms Inc^{Approved Prior To Jan 1, 1982}
Taro^{Approved Prior To Jan 1, 1982}
Teva Pharms^{May 27, 1994}
Hikma Intl Pharms^{Feb 23, 2015}
Impax Labs Inc^{Mar 30, 2007}
Pii^{Apr 27, 2017}
Vintage^{Jul 16, 2007}
Perrigo New York^{Approved Prior To Jan 1, 1982}
Rising Pharms Inc^{Aug 20, 2010}
Vintage Pharms^{Jul 30, 2003}

HYDROCORTISONE IN ABSORBASE [Hydrocortisone^{C₂₁H₃₀O₅}]

1% (topical ointment)

Cmp Pharma Inc^{Sep 6, 1985}

ICLUSIG [Ponatinib Hydrochloride^{C₂₉H₂₇F₃N₆OClH}]

eq 15mg base (oral tablet)

eq 30mg base (oral tablet)

eq 45mg base (oral tablet)

Ariad^{Dec 14, 2012}

A method for the treatment of leukemias.
A method for treating acute lymphoblastic leukemia.
A method for treating chronic myeloid leukemia.
A method for treating leukemia resulting from a mutation in the bcr-abl kinase domain.
A method for treating philadelphia chromosome positive acute lymphoblastic leukemia.
A method of treating chronic myelogenous leukemia.

INJECTAFER [Ferric Carboxymaltose^{C₁₈H₃₁O₁₇(C₆H₁₀O₅)n(Fe)mod(O)mod(HO)modH₂O}]

750mg iron/15ml (50mg iron/ml) (intravenous injectable)

Luitpold Pharms Inc^{Jul 25, 2013}

Method of treatment of iron-related conditions with at least 0.6 grams of elemental iron via an iron carbohydrate complex, with a substantially non-immunogenic carbohydrate component, in about 15 minutes or less..
Method of treatment of iron-related conditions with at least 0.6 grams of elemental iron via an iron carbohydrate complex.

ISIBLOOM [Desogestrel^{C₂₂H₃₀O} : Ethinyl Estradiol^{C₂₀H₂₄O₂}]

0.15mg : 0.03mg (oral-28 tablet)

Sandoz Inc^{Aug 12, 2015}

KALLIGA [Desogestrel^{C₂₂H₃₀O} : Ethinyl Estradiol^{C₂₀H₂₄O₂}]

0.15mg : 0.03mg (oral-28 tablet)

Aurobindo Pharma Ltd^{May 17, 2017}

KARIVA [Desogestrel^{C₂₂H₃₀O} : Ethinyl Estradiol^{C₂₀H₂₄O₂}]

0.15mg,n/a : 0.02mg,0.01mg (oral-28 tablet)

Barr^{Apr 5, 2002}

KIMIDESS [Desogestrel^{C₂₂H₃₀O} : Ethinyl Estradiol^{C₂₀H₂₄O₂}]

0.15mg,n/a : 0.02mg,0.01mg (oral-28 tablet)

Vintage Pharms^{Apr 30, 2015}

LOMOTIL [Atropine Sulfate^{2C₁₇H₂₃NO₃H₂OH₂O₄S} : Diphenoxylate Hydrochloride^{C₃₀H₃₂N₂O₂ClH}]

0.025mg : 2.5mg (oral tablet)

Gd Searle Llc^{Approved Prior To Jan 1, 1982}

MENEST [Estrogens, Esterified]

0.3mg (oral tablet)

0.625mg (oral tablet)

1.25mg (oral tablet)

2.5mg (oral tablet)

Monarch Pharms^{Approved Prior To Jan 1, 1982}

MOXATAG [Amoxicillin^{C₁₆H₁₉N₃O₅S3H₂O}]

775mg (oral tablet, extended release)

Vernalis R And D Ltd^{Jan 23, 2008}

Method of treating tonsillitis and/or pharyngitis secondary to streptococcus pyogenes in a once-a-day amoxicillin product.
Use of once-a-day amoxicillin product to treat tonsillitis and/or pharyngitis secondary to streptococcus pyogenes.

MYFORTIC [Mycophenolic Acid^{C₁₇H₂₀O₆}]

180mg (oral tablet, delayed release)

360mg (oral tablet, delayed release)

Novartis^{Feb 27, 2004}

Prophylaxis of organ rejection in patients receiving allogeneic renal transplants.

NATESTO [Testosterone^{C₁₉H₂₈O₂}]

5.5mg/0.122gm actuation (nasal gel, metered)

Aytu Bioscience Inc^{May 28, 2014}

A method of testosterone replacement therapy comprising the step of nasally administering to a patient in need of such treatment an effective amount of testosterone gel formulation..
Nasal administration of a testosterone gel to a patient to treat the patient for a condition associated with a deficiency or absence of endogenous testosterone.

OGEN 5 [Estropipate^{C₁₈H₂₂O₅SC₄H₁₀N₂}]

6mg (oral tablet)

Pharmacia And Upjohn^{Approved Prior To Jan 1, 1982}

OSPHENA [Ospemifene^{C₂₄H₂₃ClO₂}]

60mg (oral tablet)

Duchesnay^{Feb 26, 2013}

Treatment of dyspareunia associated with menopause.
Treatment of vaginal symptoms of urogenital atrophy by orally administering ospemifene with food to enhance bioavailability of ospemifene.

PIMTREA [Desogestrel^{C₂₂H₃₀O} : Ethinyl Estradiol^{C₂₀H₂₄O₂}]

0.15mg,n/a : 0.02mg,0.01mg (oral-28 tablet)

Novast Labs Ltd^{Aug 1, 2013}

PREMARIN [Estrogens, Conjugated]

0.3mg (oral tablet)

0.45mg (oral tablet)

0.625mg (oral tablet)

0.625mg/gm (topical, vaginal cream)

0.9mg (oral tablet)

1.25mg (oral tablet)

25mg/vial (injection injectable)

Wyeth Pharms Inc^{Approved Prior To Jan 1, 1982}

PREMPHASE 14/14 [Estrogens, Conjugated : Medroxyprogesterone Acetate^{C₂₄H₃₄O₄}]

0.625mg,0.625mg : n/a,5mg (oral-28 tablet)

Wyeth Pharms Inc^{Nov 17, 1995}

PREMPRO [Estrogens, Conjugated : Medroxyprogesterone Acetate^{C₂₄H₃₄O₄}]

0.3mg : 1.5mg (oral-28 tablet)

0.45mg : 1.5mg (oral-28 tablet)

0.625mg : 2.5mg (oral-28 tablet)

0.625mg : 5mg (oral-28 tablet)

Wyeth Pharms Inc^{Jun 4, 2003}

RAVICTI [Glycerol Phenylbutyrate^{C₃₃H₃₈O₆}]

1.1gm/ml (oral liquid)

Horizon Theraps Inc^{Feb 1, 2013}

Dosage adjustment of a nitrogen scavenging drug in the treatment of a urea cycle disorder.
Treatment of a nitrogen metabolism disorder.
Treatment of a urea cycle disorder.

REVLIMID [Lenalidomide^{C₁₃H₁₃N₃O₃}]

10mg (oral capsule)

15mg (oral capsule)

2.5mg (oral capsule)

20mg (oral capsule)

Celgene^{Dec 27, 2005}

Treatment of male patient having a disease or condition responsive to a teratogenic drug.
Use of revlimid (lenalidomide) for the treatment of mantle cell lymphoma (mcl).
Use of revlimid (lenalidomide) for the treatment of multiple myeloma and transfusion-dependent anemia in myelodysplastic syndromes (mds).
Use of revlimid (lenalidomide) for the treatment of multiple myeloma.
Use of revlimid (lenalidomide) for the treatment of transfusion-dependent anemia in myelodysplastic syndromes (mds).
Use of revlimid (lenalidomide) to inhibit the secretion of pro-inflammatory cytokines, including tumor necrosis factor alpha.
Use of revlimid (lenalidomide) while preventing the exposure of a fetus or other contraindicated individual to revlimid (lenalidomide).

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.

WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for reference only. Many of these treatments may be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field. The owner of this website will not be held liable for any injuries and deaths cause by following any home remedies. We have no control of what is posted.

Home Remedies for Ogen

SORE THROAT [pharyngitis]
Garlic (Allium Sativum) has antibacterial properties against cariogenic bacteria (Streptococcus mutans and Lactobacillus acidophilus). Garlic juice can be used as a mouthwash to treat plaque or mouth sores.
Mechanism - allicinJlaiii | August 9th, 2020

Reference:

Kshirsagar, Minal M., Dodamani, Arun S., Karibasappa, Gundbakhta N., et al. Antibacterial Activity Of Garlic Extract On Cariogenic Bacteria- An In Vitro Stu. Ayu 39(3) 165 to 168.¹

WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for historical reference only. Many of these treatments are now known to be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field.

Felter's Materia Medica on Ogen

AVENA SATIVA
The unripe seed of the Avena sativa, Linné, and the farina derived from the ripened seed (Nat. Ord. Graminaceae). Probably indigenous to Sicily... / ...at. Principal Constituents.Starch, oil, albumen, potassium and magnesium salts, silica, and a nitrogenous body, avenine. Preparations.1. Avenae Farina, Oatmeal. Chiefly a food and to prepare oatme... / ...off the habit has not been sustained. In our own experience we have utterly failed to accomplish any good with it in any form of drug habit. ²

CHIONANTHUS
The bark of the root of Chionanthus virginicus, Linné. (Nat. Ord. Oleaceae.) United States from Pennsylvania southward. Dose, 5 to 30... / ...to credence that chionanthus is a potent and satisfactory medicinal aid in glycosuria, when the glycogenic function of the liver is at fault. While it is believed to have some effect upon the function... / ...never reach the true diabetic state. There is good reason to believe that the prolonged use of chionanthus will be of much benefit in such cases.²

GLYCERINUM
Glycerin, Glycerol. A liquid composed most largely of a trihydric alcohol (C3H5(OH)3) obtained by the processes of hydrolysis and distillation of... / ...t least, a food, and indirectly a conservator of fats through its effects of increasing the non-nitrogenous reserve of the body. It is also believed to increase energy. Upon the glycogenic function it... / ...A 5 per cent solution of phenol in glycerin upon cotton may be used for insertion into the aural canal after rupture of the membrana tympani wh²

SENNA^SENNA
The dried leaflets of (1) Cassia acutifolia, Delile, or of (2) Cassia angustifolia, Vahl (Nat. Ord. Leguminosae). (1) Eastern and central Africa;... / ...n amorphous, water-soluble, sulphurated glucosidecathartinic acid (which may be split into cathartogenic acid and glucose), emodin, sennacrol and sennapicrin (water-insoluble glucosides), and chryso... / ...woman, and for children. It may be given in water, or the readyprepared lozenges may be used, the patient partaking also of plenty of water.²

Physician's Materia Medica on Ogen

HAEMOGLOBOGEN
A hematinic tonic, which combines the characters of a predigested nitrogenous food with those of a blood renewing agent. The pre paration is somewhat richer in iron than Haemo-mangan (q. v.), which preparation this resembles in composition and properties, Dose, 4 to 15 c. c. (1 to 4 fluidrachms) after each meal.³

NUTRIENT PEPTONES
A preparation representing the nitrogenous elements of beef, milk and cereal grains in a vinous vehicle. The nutrient value of such a preparation is far higher than that of a wine or elixir of beef prepared from the extract of beef. Taken in connection with meals, the preparation serves to assist digestion by a direct stimulant action on the glands of the stom ach. It is of use, therefore, not only in convalescence from acute illness, but in enfeebled conditions of the system generally where the³

NUTRIENT PEPTONES WITH CREOSOTE
This preparation combines with the peptonized nitrogenous con stituents of beef, milk and cereal grains as much Creosote and Guaia col as can be rendered at all palatable. It constitutes thus a highly concentrated, predigested food, having also the stimulant properties of the wine which forms the vehicle, and a powerful bactericidal action due to the creosote present. The combination is one admira bly adapted to meet the indications in a wasting disease like phthisis, and experience has shown th³

Physician's Therapeutics Memoranda on Ogen

ABSCESS
In the incipient stage, applications of tincture iodine, of Phenol camphor, N., B. & Co. or of a... / ... its de pletant and emollient eifect; anodynes as needed. If pus forms, evacuate it early and dress with Iodosyl gauze, cleaning when needed with hydrogen peroxide and applying finally ointment of zinc oxide. Sustain strength by wholesome nourishing food and such tonics as Eupeptic Hypophosphites, V...³

CATARRH, NASAL (See also Coryza)
Chronic Nasal Catarrh in our climate is an intractable affection. In mild cases Alkal-Antiseptine, well diluted with water and ap plied twice daily by aid of the little douche that accompanies it, is all the treatment needed. Application of Iodosyl once daily has a most happy effect. Tonics are often indicated. Atrophic Nasal Catarrh calls for use of more active antiseptics and a stimulating treatment, silver nitrate, iodine and hydrogen peroxide being the most useful remediés.³

DIPHTHERIA AND MEMBRANOUS CROUP
Isolate the patient and watch... / ... all children who may have been exposed. In every case use Diphtheria Antitoxin if at hand and use it promptly. As local application, peroxide of hydrogen is most satisfactory. Loefl1er’s solution (menthol, 100 grs. dissolved in 6 fluidrachms toluol, with addition of 40 minims solution ferric chlo...³

FRECKLES
A lotion of mecuric chloride, 3 grs., milk of almonds, 4 fl. ozs., ap plied night and morning is aneflicient remedy; boric acid in saturat ed aqueous solution; a solution of zinc sulphocarbolate, 5 grs. to the fl. oz.; a lotion of rose water and glycerin with zinc oxide and a little ammoniated mercury; hydrogen peroxide.³

GANGRENE
Bromine is the most e lcient escharotic; chromic acid and nitric acid are often used. Carbolic acid applied in full strength, followed by alcohol to limit its action, with subsequent dressing with Iodosyl has given excellent results. For cleansing, hydrogen peroxide is eflicient. Ichthyol and boric acid may be used in dressing, but Iodosyl is better. Internally guaiacol and creosote to guard against p yemia.³

ULCERS
The treatment must depend on the conditions. In general the applications that are of most benefit are at once stimulating and antiseptic. That most generally useful is Iodosyl. As a cleansing agent, hydrogen peroxide is generally best, although more powerful applications (caustics) have their use, particularly strong carbolic acid followed by alcohol to limit its destructive action.³

References

1) Kshirsagar, Minal M., Dodamani, Arun S., Karibasappa, Gundbakhta N., et al. Antibacterial Activity Of Garlic Extract On Cariogenic Bacteria- An In Vitro Stu. Ayu 39(3) 165 to 168.
2) Felter, Harvey Wickes, 1922, The Eclectic Materia Medica, Pharmacology and Therapeutics, Cincinnati, Ohio.
3) Nelson, Baker & Co., 1904, Physician's Handy Book of Materia Medica and Therapeustics, Detroit, Michigan.

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Ogen FDA Approved Drugs

Home Remedies for Ogen

Felter's Materia Medica on Ogen

Physician's Materia Medica on Ogen

Physician's Therapeutics Memoranda on Ogen

References